ConductScience.org, home

Paper36915194

Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.

Martínez-Férriz A and 5 others. Cell Commun Signal, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity. Papers, record 36915194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915194

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.
PubMed
Journal
Cell Commun Signal
PubMed
Year
2023
PubMed
Publication types
Video-Audio Media, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2023-03-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martínez-Férriz AArantxa
2Gandía CCarolina
3Pardo-Sánchez JMJosé Miguel
4Fathinajafabadi AAlihamze
5Ferrando AAlejandro
6Farràs RRosa

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Humans
Mice
Animals
Ribosomes
Peptide Initiation Factors
Puromycin

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122722845A tumour suppressor network relying on the polyamine-hypusine axis.Nature2012https://conductscience.org/library/papers/22722845PubMed
227637266Localized translation regulates cell adhesion and transendothelial migration.J Cell Sci2016https://conductscience.org/library/papers/27637266PubMed
319424157Hypusine-containing protein eIF5A promotes translation elongation.Nature2009https://conductscience.org/library/papers/19424157PubMed
414166766PUROMYCIN INHIBITION OF PROTEIN SYNTHESIS: INCORPORATION OF PUROMYCIN INTO PEPTIDE CHAINS.Proc Natl Acad Sci U S A1964https://conductscience.org/library/papers/14166766PubMed
58347280Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.Biofactors1993https://conductscience.org/library/papers/8347280PubMed
620112425Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.Hepatology2010https://conductscience.org/library/papers/20112425PubMed
725979826The translation factor eIF5A and human cancer.Biochim Biophys Acta2015https://conductscience.org/library/papers/25979826PubMed
824923804Fertility and polarized cell growth depends on eIF5A for translation of polyproline-rich formins in Saccharomyces cerevisiae.Genetics2014https://conductscience.org/library/papers/24923804PubMed
911161802Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression.Genomics2001https://conductscience.org/library/papers/11161802PubMed
1029428664EIF5A1 promotes epithelial ovarian cancer proliferation and progression.Biomed Pharmacother2018https://conductscience.org/library/papers/29428664PubMed
1134198671Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation.Cancers (Basel)2021https://conductscience.org/library/papers/34198671PubMed
127759117The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2.Genomics1995https://conductscience.org/library/papers/7759117PubMed
1323322277Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.J Cancer Res Clin Oncol2013https://conductscience.org/library/papers/23322277PubMed
1431195692TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.Int J Mol Sci2019https://conductscience.org/library/papers/31195692PubMed
1520830705Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.Int J Cancer2011https://conductscience.org/library/papers/20830705PubMed
1616519677Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.FEBS J2006https://conductscience.org/library/papers/16519677PubMed
177961711Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines.J Biol Chem1994https://conductscience.org/library/papers/7961711PubMed
1824250246Roles of eukaryotic initiation factor 5A2 in human cancer.Int J Biol Sci2013https://conductscience.org/library/papers/24250246PubMed
1932605067Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.Diagnostics (Basel)2020https://conductscience.org/library/papers/32605067PubMed
2026715760Structure of the hypusinylated eukaryotic translation factor eIF-5A bound to the ribosome.Nucleic Acids Res2016https://conductscience.org/library/papers/26715760PubMed

See all 48 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41390489Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation.Nat Commun2025https://conductscience.org/library/papers/41390489PubMed
40936684Integration of single-cell and bulk RNA sequencing to identify unique tumor stem cells and construct novel prognostic markers for assessing ESCA prognosis and drug sensitivity.Front Oncol2025https://conductscience.org/library/papers/40936684PubMed
40040695Polyamine metabolism and anti-tumor immunity.Front Immunol2025https://conductscience.org/library/papers/40040695PubMed
39959839Integrated genomic analysis of the stemness index signature of mRNA expression predicts lung adenocarcinoma prognosis and immune landscape.PeerJ2025https://conductscience.org/library/papers/39959839PubMed
39934701Multi-omics analysis reveals the impact of YAP/TEAD4-mediated EIF5A1 expression on mitochondrial apoptosis and bladder cancer progression.BMC Cancer2025https://conductscience.org/library/papers/39934701PubMed
38276673Toxoplasma gondii eIF-5A Modulates the Immune Response of Murine Macrophages In Vitro.Vaccines (Basel)2024https://conductscience.org/library/papers/38276673PubMed
38229033SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells.Cell Mol Biol Lett2024https://conductscience.org/library/papers/38229033PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36915194

GET https://conductscience.org/api/papers/v1/36915194/references?page=2